Glaukos Corporation (GKOS)

業務介紹

Glaukos Corporation是一家眼科醫療技術和製藥公司，專注於開發新型治療青光眼、角膜疾病和視網膜疾病的療法。該公司提供iStent、iStent inject、iStent inject W微型旁路支架等產品，這些產品可增強房水排出，並在白內障手術中植入，用於治療輕至中度開角青光眼。該公司的產品管道還包括iStent Infinite，這是一種三支架產品，旨在用於對抗青光眼無效的患者作為獨立手術；以及iDose TR，這是一種基於其微型裝置平台的靶向可注射植入物，旨在提供治療劑量的藥物。該公司通過直接銷售組織以及在美國和國際市場上通過分銷商銷售其產品。Glaukos Corporation成立於1998年，總部位於加利福尼亞州聖克萊門特。

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

公司網址

https://www.glaukos.com